Development of coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the current endemic ...

Pegasus Resources Inc. (the "Company" or "Pegasus") is pleased to announce that it has closed the final tranche of the non-brokered private placement Offering, raising gross proceeds of $223, ...

Palantir's 2024 run is showing no signs of cooling, with the stock's inclusion in the S&P 500 index is seemingly beginning to ...